Le Lézard
Classified in: Health, Business
Subjects: CON, PDT

Dutch Hospital Expands its Use of Sectra's Medical Imaging Solution to Include Digital Pathology


LINKÖPING, Sweden and ALMERE, the Netherlands, Jan. 22, 2020 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed a digital pathology contract with the Dutch hospital Zuyderland MC. A digital pathology workflow makes it possible to access and share images and information between departments and hospitals. Storing, reviewing and sharing digital pathology images increases efficiency in primary diagnostics and improves cancer care by facilitating the handling of complex cases.

With digital images of tissue samples instead of physical glass slides, pathologists gain instant access to current and historical images and related data as well as digital tools for reviewing the images. 

"When moving to full-scale digital pathology for primary diagnostics, it's vital to select a solution that is stable, fast and allows integration with the scanners and LIS of our choice. Sectra's digital pathology solution meets all these criteria," says Danny Goudkade, Pathologist at Zuyderland MC. "We already use Sectra's solution for radiology and know that they are a great vendor to work with."

The digital solution provides pathologists with assistance at critical decision points, such as grading or performing more precise measurements. It also enables image analysis, which in turn reduces variation and improves the precision of tasks such as cell counting. Digital access also facilitates second opinions, external reading resources, specialist consultations and makes integrated diagnostics possible.

Sectra's digital pathology solution will be integrated with Zuyderland's laboratory information system (LIS). This will provide pathologists with a complete overview of the patient history in one application and enable workflow orchestration to drive the workflow according to sub-specialties, rules and priorities. The solution's vendor-neutral approach also gave Zuyderland the freedom to select the scanner vendor of their choice. By using Sectra's solution for both radiology and pathology, Zuyderland is well equipped to move towards integrated diagnostic workflows should they choose to do so in the future.

The solution will handle approximately 35,000 examinations per year. The seven-year contract was signed in December 2019. 

In 2017, Sectra announced that Zuyderland purchased its solution for handling radiology images. Read more about it >>

The pathology solution is part of Sectra's enterprise imaging offering. It provides a unified strategy for all imaging needs, and improves patient outcomes while lowering operational costs. The scalable and modular solution supports the most image-intense departments-radiology, breast imaging, pathology, cardiology and orthopaedics. Being built on the same technical platform, customers can easily extend a departmental solution to create a comprehensive VNA. Read more about Sectra's enterprise imaging solution and why Sectra PACS is "Best in KLAS" at https://medical.sectra.com/.

Meet Sectra at HIMSS and ECR 2020

Sectra's enterprise imaging solution, including digital pathology, will be showcased at the HIMSS and ECR trade shows. Visit booth #6248 at HIMSS and #D11 at ECR to learn more about the solution.

Book a meeting at HIMSS >> 

Book a meeting at ECR >>

About Sectra

Sectra assists hospitals throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society's most sensitive information. Thereby, Sectra contributes to a healthier and safer society. The company was founded in 1978, has its head office in Linköping, Sweden, with direct sales in 19 countries, and operates through partners worldwide. Sales in the 2018/2019 fiscal year totaled SEK 1,413 million. The Sectra share is quoted on the Nasdaq Stockholm exchange. For more information, visit https://sectra.com/.

For further information, please contact:

Dr. Torbjörn Kronander
CEO and President Sectra AB 
46(0)705-23-52-27

Marie Ekström Trägårdh
Executive Vice President Sectra AB and President Sectra Imaging IT Solutions
46(0)708-23-56-10

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/sectra/r/dutch-hospital-expands-its-use-of-sectra-s-medical-imaging-solution-to-include-digital-pathology,c3013762

The following files are available for download:

https://news.cision.com/sectra/i/sectra-digital-pathology,c2738340

Sectra digital pathology

SOURCE Sectra


These press releases may also interest you

at 01:00
PARIS, FRANCE, 24 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the first quarter of 2024. ? ?  Q1 2024? Q1 2023? % change? ?m? ?m? ActualCER1Growth...

23 avr 2024
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

23 avr 2024
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

23 avr 2024
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...

23 avr 2024
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...

23 avr 2024
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...



News published on and distributed by: